A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Small Cell Lung Cancer ( SCLC )Lambert Eaton Myasthenic Syndrome (LEMS)
Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Addario Lung Cancer Medical Institute

OTHER